Results of travel grant competition for young scientists from regional RSC divisions to participate in the 1st Global Educational Forum “Russian Cardiovascular Days”

25.03.20133047
The results of travel grant competition for young scientists from regional divisions of the Russian Society of Cardiology to participate in the 1st Global Educational Forum “Russian Cardiovascular Days”

Excess salt blamed for 2.3 million deaths from CVD worldwide in 2010

22.03.20131987
Researchers estimate that in 2010, adults in most parts of the world consumed about twice as much salt as recommended.

Chlorthalidone Versus Hydrochlorothiazide for the Treatment of Hypertension in Older Adults: A Population-Based Cohort Study

21.03.20132134
Some evidence suggests that chlorthalidone may be superior to hydrochlorothiazide for the treatment of hypertension.

"High-potency" statins linked to acute kidney injury in analysis

20.03.20132693
Taking statins at "high-potency" dosages, with levels depending on the agent, appears to raise the adjusted risk of acute kidney injury by 34% over the first four months of treatment, compared with taking lower-dose statins, suggests an analysis.

The Effect of CRT Therapy on RV Function in Patients with Severe LV Dysfunction: A Matched Control Study

19.03.20132061
Whilst numerous studies have established the prognostic and symptomatic benefits of cardiac resynchronization therapy (CRT) on left ventricle (LV), its effect on right ventricular (RV) function has not been well described.

Clopidogrel/atorvastatin protect in carotid stenting

18.03.20132398
A 600 mg clopidogrel loading dose reduced periprocedural ischemic cerebral events and rates of transient ischemic attack (TIA) and stroke at 30 days in patients undergoing carotid stenting in the ARMYDA-9 CAROTID study.

Hints of renal-denervation side benefit: Fewer ventricular arrhythmias

15.03.20132006
Согласно данным исследования, представленного на этой неделе на научной сессии в Американском колледже кардиологов, симпатическая почечной денервации достигла своих целей в снижении артериального давления и частоты сердечных сокращений особенно у пациентов высокого риска с лекарственно устойчивой гипертонией, а также она привела к уменьшению желудочковых и наджелудочковых аритмий.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.